Literature DB >> 32458362

Biliopancreatic Limb Length in One Anastomosis Gastric Bypass: Which Is the Best?

Francesco Pizza1, Francesco Saverio Lucido2, Dario D'Antonio3, Salvatore Tolone2, Claudio Gambardella2, Chiara Dell'Isola4, Ludovico Docimo2, Alberto Marvaso3.   

Abstract

BACKGROUND: The use of one anastomosis gastric bypass (OAGB) is rapidly spreading. Concerns about biliary reflux and malabsorption with consequent nutritional deficits exist, so studies on biliopancreatic limb (BPL) adequate length in OAGB are required to balance excess weight loss in percentage (% EWL), resolution of comorbidities, and nutritional deficit. The purpose was to evaluate, at 2 years after OAGB, the effects of BPL length on weight loss, resolution of comorbidity, and nutritional deficiencies in patients.
METHODS: From January 2015 to January 2017, 180 patients were collected into three groups based BPL length: group A, 150 cm; group B, 180 cm; and group C, 200 cm. Aims were to compare %EWL, co-morbidity resolution rates, nutritional parameters, and morbidity/mortality in the three groups.
RESULTS: The total number of patients was 180: 60 for each group. One hundred seventy-two (95%) patients attended the 1-year follow-up (group A = 58; group B = 58, group C = 56). One hundred fifty-seven (87%) patients attended the 2-year follow-up (group A = 52 (87%); group B = 53 (88%); group C = 52 (87%)). There was no statistically significant difference in %EWL, %TWL, T2DM, and hypertension resolution rates among the groups. About vitamin deficiency, differences were not statistically significant. Iron and ferritin deficiency rate were statistically significant only between A and C groups.
CONCLUSIONS: According to our evidence, standardization of BPL length shorter than 200 cm is suggested, potentially minimizing malnutrition-related outcomes. Our study seems to show that a BPL of 150-180 cm is safe and effective in terms of EWL and comorbidity improvement with low malnutrition effects even in BMI > 50.

Entities:  

Keywords:  Malabsorption; Nutritional deficiencies; Obesity surgery; One anastomosis gastric bypass

Mesh:

Year:  2020        PMID: 32458362     DOI: 10.1007/s11695-020-04687-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  14 in total

1.  The Hardship of Recovering a Patient from Liver Failure after One Anastomosis Gastric Bypass.

Authors:  Ashraf Haddad; Ahmad Bashir
Journal:  Obes Surg       Date:  2021-01-08       Impact factor: 4.129

2.  The IFSO Worldwide One Anastomosis Gastric Bypass Survey: Techniques and Outcomes?

Authors:  Ashraf Haddad; Ahmad Bashir; Mathias Fobi; Kelvin Higa; Miguel F Herrera; Antonio J Torres; Jacques Himpens; Scott Shikora; Almino Cardoso Ramos; Lilian Kow; Abdelrahman Ali Nimeri
Journal:  Obes Surg       Date:  2021-01-31       Impact factor: 4.129

Review 3.  Effect of Biliopancreatic Limb Length on Weight Loss, Postoperative Complications, and Remission of Comorbidities in One Anastomosis Gastric Bypass: a Systematic Review and Meta-analysis.

Authors:  Erfan Tasdighi; Maryam Barzin; Kamal K Mahawar; Farhad Hosseinpanah; Amir Ebadinejad; Nazanin Taraghikhah; Anahita Mansoori; Alireza Khalaj; Mahtab Niroomand; Majid Valizadeh; Behnaz Abiri
Journal:  Obes Surg       Date:  2022-01-29       Impact factor: 4.129

4.  Revisional Surgery of One Anastomosis Gastric Bypass for Severe Protein-Energy Malnutrition.

Authors:  Adam Abu-Abeid; Or Goren; Shai Meron Eldar; Antonio Vitiello; Giovanna Berardi; Guy Lahat; Danit Dayan
Journal:  Nutrients       Date:  2022-06-06       Impact factor: 6.706

5.  What Is the Efficacy of Short Length of Biliopancreatic Limb in One-Anastomosis Gastric Bypass? A Systematic Review and Meta-analysis of Short-Term Results.

Authors:  Yichen Li; Yijie Gu; Yujia Jin; Zhongqi Mao
Journal:  Obes Surg       Date:  2022-04-24       Impact factor: 3.479

6.  Biliopancreatic Limb Length of Small Intestinal Bypass in Non-obese Goto-Kakizaki (GK) Rats Correlates with Gastrointestinal Hormones, Adipokines, and Improvement in Type 2 Diabetes.

Authors:  Qiwei Zhang; Zhi Hong; Jieyao Zhu; Chao Zeng; Zhen Tang; Weiqiang Wang; He Huang
Journal:  Obes Surg       Date:  2021-07-26       Impact factor: 4.129

Review 7.  Bariatric Surgery-How Much Malabsorption Do We Need?-A Review of Various Limb Lengths in Different Gastric Bypass Procedures.

Authors:  Daniel Moritz Felsenreich; Felix Benedikt Langer; Jakob Eichelter; Julia Jedamzik; Lisa Gensthaler; Larissa Nixdorf; Mahir Gachabayov; Aram Rojas; Natalie Vock; Marie Louise Zach; Gerhard Prager
Journal:  J Clin Med       Date:  2021-02-10       Impact factor: 4.241

8.  Revisional Surgery After One Anastomosis/Minigastric Bypass: an Italian Multi-institutional Survey.

Authors:  Mario Musella; Antonio Vitiello; Antonio Susa; Francesco Greco; Maurizio De Luca; Emilio Manno; Stefano Olmi; Marco Raffaelli; Marcello Lucchese; Sergio Carandina; Mirto Foletto; Francesco Pizza; Ugo Bardi; Giuseppe Navarra; Angelo Michele Schettino; Paolo Gentileschi; Giuliano Sarro; Sonja Chiappetta; Andrea Tirone; Giovanna Berardi; Nunzio Velotti; Diego Foschi; Marco Zappa; Luigi Piazza
Journal:  Obes Surg       Date:  2022-01-01       Impact factor: 4.129

9.  Tailored one anastomosis gastric bypass - Subgroup analysis of a randomised control trial based on bilio-pancreatic limb length with long-term results of 101 patients.

Authors:  Mayank Jain; Om Tantia; Ghanshyam Goyal; Tamonas Chaudhuri; Shashi Khanna; Anshuman Poddar; Kajari Majumdar; Sonam Gupta
Journal:  J Minim Access Surg       Date:  2022 Apr-Jun       Impact factor: 1.407

10.  The importance of patient selection in bariatric surgery: One not fit for all. Case report of a preventable double severe complication after Laparoscopic gastric banding positioning.

Authors:  Francesco Saverio Lucido; Giuseppe Scognamiglio; Alessandro Salvucci; Claudio Gambardella; Luigi Brusciano; Gianmattia Del Genio; Francesco Pizza; Domenico Parmeggiani; Simona Parisi; Mariachiara Lanza Volpe
Journal:  Int J Surg Case Rep       Date:  2020-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.